1
|
Malouf C and Ottersbach K: Molecular
processes involved in B cell acute lymphoblastic leukaemia. Cell
Mol Life Sci. 75:417–446. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Tasian SK and Hunger SP: Genomic
characterization of paediatric acute lymphoblastic leukaemia: An
opportunity for precision medicine therapeutics. Br J Haematol.
176:867–882. 2017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Moorman AV: New and emerging prognostic
and predictive genetic biomarkers in B-cell precursor acute
lymphoblastic leukemia. Haematologica. 101:407–416. 2016.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Moorman AV, Harrison CJ, Buck GA, Richards
SM, SeckerWalker LM, Martineau M, Vance GH, Cherry AM, Higgins RR,
Fielding AK, et al: Karyotype is an independent prognostic factor
in adult acute lymphoblastic leukemia (ALL): Analysis of
cytogenetic data from patients treated on the Medical Research
Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG)
2993 trial. Blood. 109:3189–3197. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hamadeh L, Enshaei A, Schwab C, Alonso CN,
Attarbaschi A, Barbany G, den Boer ML, Boer JM, Braun M, Dalla
Pozza L, et al: Validation of the United Kingdom copy-number
alteration classifier in 3239 children with B-cell precursor ALL.
Blood Adv. 3:148–157. 2019. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ribera J, Zamora L, Morgades M, Mallo M,
Solanes N, Batlle M, Vives S, Granada I, Juncà J, Malinverni R, et
al: Copy number profiling of adult relapsed B-cell precursor acute
lymphoblastic leukemia reveals potential leukemia progression
mechanisms. Genes Chromosomes Cancer. 56:810–820. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Irving JA, Enshaei A, Parker CA, Sutton R,
Kuiper RP, Erhorn A, Minto L, Venn NC, Law T, Yu J, et al:
Integration of genetic and clinical risk factors improves
prognostication in relapsed childhood B-cell precursor acute
lymphoblastic leukemia. Blood. 128:911–922. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Öfverholm I, Tran AN, Olsson L,
Zachariadis V, Heyman M, Rudd E, Syk Lundberg E, Nordenskjöld M,
Johansson B, Nordgren A and Barbany G: Detailed gene dose analysis
reveals recurrent focal gene deletions in pediatric B-cell
precursor acute lymphoblastic leukemia. Leuk Lymphoma.
57:2161–2170. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Othman MA, Melo JB, Carreira IM, Rincic M,
Glaser A, Grygalewicz B, Gruhn B, Wilhelm K, Rittscher K, Meyer B,
et al: High rates of submicroscopic aberrations in karyotypically
normal acute lymphoblastic leukemia. Mol Cytogenet. 8:452015.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Mangum DS, Downie J, Mason CC, Jahromi MS,
Joshi D, Rodic V, Müschen M, Meeker N, Trede N, Frazer JK, et al:
VPREB1 deletions occur independent of lambda light chain
rearrangement in childhood acute lymphoblastic leukemia. Leukemia.
28:216–220. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Claussen U, Michel S, Mühlig P, Westermann
M, Grummt UW, Kromeyer-Hauschild K and Liehr T: Demystifying
chromosome preparation and the implications for the concept of
chromosome condensation during mitosis. Cytogenet Genome Res.
98:136–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Shaffer LG, McGowan-Jordan J and Schmid M:
An International System for Human Cytogenetic Nomenclature. Karger;
Basel: pp. 2108–2109. 2013
|
13
|
Liu X and Harada S: RNA isolation from
mammalian samples. Curr Protoc Mol Biol. Chapter 4:Unit 4.16. 2013.
View Article : Google Scholar : PubMed/NCBI
|
14
|
van Dongen JJ, Macintyre EA, Gabert JA,
Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G,
Griesinger F, et al: Standardized RT-PCR analysis of fusion gene
transcripts from chromosome aberrations in acute leukemia for
detection of minimal residual disease. Report of the BIOMED-1
Concerted Action: Investigation of minimal residual disease in
acute leukemia. Leukemia. 13:1901–1928. 1999. View Article : Google Scholar : PubMed/NCBI
|
15
|
Weise A, Mrasek K, Fickelscher I, Claussen
U, Cheung SW, Cai WW, Liehr T and Kosyakova N: Molecular definition
of high-resolution multicolor banding probes: First within the
human DNA sequence anchored FISH banding probe set. J Histochem
Cytochem. 56:487–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Liehr T: Fluorescence In Situ
Hybridization (FISH)-Application Guide. Springer Verlag; Berlin:
2017
|
17
|
Coccé MC, Alonso CN, Rossi J, Felice MS,
Gitter MR and Gallego MS: A case of pediatric ALL with
t(16;21)(p11.2;q22) and FUS-ERG rearrangement. Blood Res. 50:55–58.
2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Aman P, Ron D, Mandahl N, Fioretos T, Heim
S, Arheden K, Willén H, Rydholm A and Mitelman F: Rearrangement of
the transcription factor gene CHOP in myxoid liposarcomas with
t(12;16)(q13;p11). Genes Chromosomes Cancer. 5:278–285. 1992.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Naro C, Bielli P, Pagliarini V and Sette
C: The interplay between DNA damage response and RNA processing:
The unexpected role of splicing factors as gatekeepers of genome
stability. Front Genet. 6:1422015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhou Y, Liu S, Oztürk A and Hicks GG:
FUS-regulated RNA metabolism and DNA damage repair: Implications
for amyotrophic lateral sclerosis and frontotemporal dementia
pathogenesis. Rare Dis. 2:e295152014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Noort S, Zimmermann M, Reinhardt D,
Cuccuini W, Pigazzi M, Smith J, Ries RE, Alonzo TA, Hirsch B,
Tomizawa D, et al: Prognostic impact of t(16;21)(p11;q22) and
t(16;21)(q24;q22) in pediatric AML: A retrospective study by the
I-BFM Study Group. Blood. 132:1584–1592. 2018. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zerkalenkova E, Panfyorova A, Kazakova A,
Baryshev P, Shelihova L, Kalinina I, Novichkova G, Maschan M,
Maschan A and Olshanskaya Y: Molecular characteristic of acute
leukemias with t(16;21)/FUS-ERG. Ann Hematol. 97:977–988. 2018.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Atak ZK, Gianfelici V, Hulselmans G, De
Keersmaecker K, Devasia AG, Geerdens E, Mentens N, Chiaretti S,
Durinck K, Uyttebroeck A, et al: Comprehensive analysis of
transcriptome variation uncovers known and novel driver events in
T-cell acute lymphoblastic leukemia. PLoS Genet. 9:e10039972013.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Mitelman F, Johansson B and Mertens F:
Mitelman Database of Chromosome Aberrations and Gene Fusions in
Cancer. National Cancer Institute; Bethesda, MD: April 18–2019
|
25
|
Liu Y, Easton J, Shao Y, Maciaszek J, Wang
Z, Wilkinson MR, McCastlain K, Edmonson M, Pounds SB, Shi L, et al:
The genomic landscape of pediatric and young adult T-lineage acute
lymphoblastic leukemia. Nat Genet. 49:1211–1218. 2017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Kathiravan M, Singh M, Bhatia P, Trehan A,
Varma N, Sachdeva MS, Bansal D, Jain R and Naseem S: Deletion of
CDKN2A/B is associated with inferior relapse free survival in
pediatric B cell acute lymphoblastic leukemia. Leuk Lymphoma.
60:433–441. 2019. View Article : Google Scholar : PubMed/NCBI
|
27
|
Agarwal M, Bakhshi S, Dwivedi SN, Kabra M,
Shukla R and Seth R: Cyclin dependent kinase inhibitor 2A/B gene
deletions are markers of poor prognosis in Indian children with
acute lymphoblastic leukemia. Pediatr Blood Cancer. 65:e270012018.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Braun M, Pastorczak A, Fendler W, Madzio
J, Tomasik B, Taha J, Bielska M, Sedek L, Szczepanski T, Matysiak
M, et al: Biallelic loss of CDKN2A is associated with poor response
to treatment in pediatric acute lymphoblastic leukemia. Leuk
Lymphoma. 58:1162–1171. 2017. View Article : Google Scholar : PubMed/NCBI
|
29
|
Donner KM, Hiltunen TP, Jänne OA, Sane T
and Kontula K: Generalized glucocorticoid resistance caused by a
novel two-nucleotide deletion in the hormone-binding domain of the
glucocorticoid receptor gene NR3C1. Eur J Endocrinol. 168:K9–K18.
2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Eswaran J, Sinclair P, Heidenreich O,
Irving J, Russell LJ, Hall A, Calado DP, Harrison CJ and Vormoor J:
The pre-B-cell receptor checkpoint in acute lymphoblastic
leukaemia. Leukemia. 29:1623–1631. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Mårtensson IL and Ceredig R: Review
article: Role of the surrogate light chain and the pre-B-cell
receptor in mouse B-cell development. Immunology. 101:435–441.
2000. View Article : Google Scholar : PubMed/NCBI
|